Citation Impact
Citing Papers
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
2013
Cell mechanics and the cytoskeleton
2010 StandoutNature
High-intensity focused ultrasound in the treatment of solid tumours
2005
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Computed Tomography — An Increasing Source of Radiation Exposure
2007 Standout
Estrogen signaling and disruption of androgen metabolism in acquired androgen‐independence during cadmium carcinogenesis in human prostate epithelial cells
2006
Idiopathic pulmonary fibrosis
2017 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
2009
Ultrastructural localization of CD38 immunoreactivity in rat brain
1997
Cancer drug resistance: an evolving paradigm
2013 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
2021
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease
2008
Capecitabine: A review
2005
The immunology of stroke: from mechanisms to translation
2011 Standout
Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate
2013
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men
2007
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Intraoperative detection and removal of microscopic residual sarcoma using wide‐field imaging
2012 StandoutNobel
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Intermediate Filament Proteins and Their Associated Diseases
2004
Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI
2007
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
2010
Are Findings from Studies of Obesity and Prostate Cancer Really in Conflict?
2006
Neuronal Calcium Signaling
1998 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Biomarkers of apoptosis
2008
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Human disorders of cortical development: from past to present
2006
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Myocarditis
2006 Standout
Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
2012
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
2003 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Associations of Serum Testosterone with Microvessel Density, Androgen Receptor Density and Androgen Receptor Gene polymorphism In prostate cancer
2003
Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil (Capecitabine, UFT, S-1): A Review
2002
Heat shock protein expression independently predicts clinical outcome in prostate cancer.
2000
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-α
2002
Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells
2014
Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development inCaenorhabditis elegans
2008 StandoutNobel
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis
2005
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
2001
Regulatory T Cells Control Dendritic Cell/NK Cell Cross-Talk in Lymph Nodes at the Steady State by Inhibiting CD4+ Self-Reactive T Cells
2008
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of Cancer
2011
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution
2001
Transcriptomes of germinal zones of human and mouse fetal neocortex suggest a role of extracellular matrix in progenitor self-renewal
2012 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
2020
Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery
2006
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
Advances in Male Contraception
2008
Cardiovascular Complications of Cancer Therapy
2004
Photothermal Response of Human and Murine Cancer Cells to Multiwalled Carbon Nanotubes after Laser Irradiation
2010
Works of Gero Kramer being referenced
Local Intratumoral Tumor Necrosis Factor- α and Systemic IFN- α 2b in Patients with Locally Advanced Prostate Cancer
2001
Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles
2006
Hypothyroidism in patients with renal cell carcinoma
2010
Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment
1998
Role of bacteria in the development of kidney stones
2000
High‐grade prostate cancer is associated with low serum testosterone levels
2001
Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue
2000
Human Dermis Harbors Distinct Mesenchymal Stromal Cell Subsets
2011
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy
2002
Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T‐cells
2003
Urolithiasis in allograft kidneys
2002
Differential expression of interleukin‐15, a pro‐inflammatory cytokine and T‐cell growth factor, and its receptor in human prostate
2001
Unenhanced Multi–Detector Row CT in Patients Suspected of Having Urinary Stone Disease: Effect of Section Width on Diagnosis
2005
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
2011
Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial
2000
Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer
2019
High Expression of a CD38-Like Molecule in Normal Prostatic Epithelium and its Differential Loss in Benign and Malignant Disease
1995
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
2019
Germline and mosaic mutations of FLN1 in men with periventricular heterotopia
2004
Phenotypic Patterns of Mononuclear Cells in Dilated Cardiomyopathy
1995
Could inflammation be a key component in the progression of benign prostatic hyperplasia?
2006
Differentiation between Cell Death Modes Using Measurements of Different Soluble Forms of Extracellular Cytokeratin 18
2004